Working… Menu
Trial record 26 of 188 for:    GLYCOPYRROLATE

"Low Dose Sugammadex Combined With Neostigmine and Glycopyrrolate Versus Full Dose Sugammadex for Reversal of Rocuronium-induced Neuromuscular Blockade: a Cost Saving Strategy"

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02375217
Recruitment Status : Completed
First Posted : March 2, 2015
Last Update Posted : June 27, 2018
Information provided by (Responsible Party):
Dr. Marie Awad, American University of Beirut Medical Center

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2015
Actual Study Completion Date : October 2015